
<?phpxml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
>
<channel>
<title>World Pharma News / alex / Voted News</title>
<link>http://www.worldpharmanews.net</link>
<description>World Pharma News .net - Web 2.0 pharmaceutical news portal</description>
<pubDate>Wed, 12 Mar 2008 00:44:52 +0200</pubDate>
<language>en</language>
<item>
<title><![CDATA[Why Big Pharma come to China]]></title>
<link>http://www.worldpharmanews.net/Corporate/Why_Big_Pharma_come_to_China/</link>
<comments>http://www.worldpharmanews.net/Corporate/Why_Big_Pharma_come_to_China/</comments>
<pubDate>Wed, 12 Mar 2008 00:44:52 +0200</pubDate>
<dc:creator>alex</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Why_Big_Pharma_come_to_China/</guid>
<description><![CDATA[Today, we take a look at large, multi-national pharmaceutical companies. Annie Fu finds out why they have come to China, and what that means for the industry. China is on the minds and lips of the CEO's of the large multi-national pharmaceutical companies, commonly referred to as Big Pharma. They are enthusiastic about China, for good reason.<br/><br/>3 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Drug Injury Watch: Tequin Revisited: Health Canada And The FDA Failed To Take Action, At Our Expense]]></title>
<link>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Tequin_Revisited_Health_Canada_And_The_FDA_Failed_To_Take_Action_At_Our_Expense-1/</link>
<comments>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Tequin_Revisited_Health_Canada_And_The_FDA_Failed_To_Take_Action_At_Our_Expense-1/</comments>
<pubDate>Wed, 12 Mar 2008 00:00:17 +0200</pubDate>
<dc:creator>tjlpa</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Tequin_Revisited_Health_Canada_And_The_FDA_Failed_To_Take_Action_At_Our_Expense-1/</guid>
<description><![CDATA[This history of Tequin -- Health Canada and FDA let the drug company Bristol-Myers Squibb sell-off its inventory of Tequin instead of ordering an immediate recall of Tequin -- appears to be a prime example of putting profits over public safety.<br/><br/>3 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[ALERT project looks to ICT for drug safety]]></title>
<link>http://www.worldpharmanews.net/Research_Development/ALERT_project_looks_to_ICT_for_drug_safety/</link>
<comments>http://www.worldpharmanews.net/Research_Development/ALERT_project_looks_to_ICT_for_drug_safety/</comments>
<pubDate>Mon, 10 Mar 2008 01:17:49 +0200</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Research &amp; Development</category>
<guid>http://www.worldpharmanews.net/Research_Development/ALERT_project_looks_to_ICT_for_drug_safety/</guid>
<description><![CDATA[A new EU-funded information and communication technology (ICT) project is tackling issues of safety in newly developed drugs. Over the next three and a half years, the ALERT ('Early detection of adverse drug events by integrative mining of clinical records and biomedical knowledge') project partners will work on an innovative computer system for a better and faster detection of adverse drug reactions (ADRs).<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Study: Post-menopause hormone pills linked to cancer - USATODAY.com]]></title>
<link>http://www.worldpharmanews.net/Research_Development/Study_Post-menopause_hormone_pills_linked_to_cancer_-_USATODAY-com/</link>
<comments>http://www.worldpharmanews.net/Research_Development/Study_Post-menopause_hormone_pills_linked_to_cancer_-_USATODAY-com/</comments>
<pubDate>Wed, 05 Mar 2008 16:11:19 +0200</pubDate>
<dc:creator>alex</dc:creator>
<category>Research &amp; Development</category>
<guid>http://www.worldpharmanews.net/Research_Development/Study_Post-menopause_hormone_pills_linked_to_cancer_-_USATODAY-com/</guid>
<description><![CDATA[Patients in the study, the Women's Health Initiative, took the hormone combination, sold under the brand name of Prempro, for an average of 5 years. Two or three years later, their risks of heart attacks, blood clots and strokes had returned to normal, according to the paper, published in today's) Journal of the American Medical Association. The pills' benefits - a decrease in the risk of fractures and colorectal cancer - also vanished.Yet &quot;the overall picture is clearly one of harm,&quot; says Marcia Stefanick, chair of the initiative's steering committee and a Stanford University School of Medicine professor. For the first time, Stefanick notes, the study findings suggest - although they don't prove - that hormone therapy also increases the risk of death, mainly because of an increase in cancer.<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Patient Lawsuits Against Pharmacuetical Companies For Drug Injuries Might Be Prohibited In U.S.]]></title>
<link>http://www.worldpharmanews.net/Blogs/Patient_Lawsuits_Against_Pharmacuetical_Companies_For_Drug_Injuries_Might_Be_Prohibited_In_U-S-/</link>
<comments>http://www.worldpharmanews.net/Blogs/Patient_Lawsuits_Against_Pharmacuetical_Companies_For_Drug_Injuries_Might_Be_Prohibited_In_U-S-/</comments>
<pubDate>Wed, 05 Mar 2008 16:04:44 +0200</pubDate>
<dc:creator>tjlpa</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Patient_Lawsuits_Against_Pharmacuetical_Companies_For_Drug_Injuries_Might_Be_Prohibited_In_U-S-/</guid>
<description><![CDATA[In late 2008 or early 2009 the Supreme Court will decide whether FDA approval of a prescription drug prohibits the filing of personal injury and wrongful death lawsuits against drug companies.<br/><br/>4 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Analyzing the side effects of drug ads - USATODAY.com]]></title>
<link>http://www.worldpharmanews.net/Blogs/Analyzing_the_side_effects_of_drug_ads_-_USATODAY-com/</link>
<comments>http://www.worldpharmanews.net/Blogs/Analyzing_the_side_effects_of_drug_ads_-_USATODAY-com/</comments>
<pubDate>Wed, 05 Mar 2008 11:48:23 +0200</pubDate>
<dc:creator>alex</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Analyzing_the_side_effects_of_drug_ads_-_USATODAY-com/</guid>
<description><![CDATA[A few times every week, patients ask Jim King about drugs they've seen advertised. &quot;They'll say, 'I saw this ad on TV, and I think I have this medical problem,'&quot; says King, a family physician in Selmer, Tenn., who says he's not bothered by the requests. &quot;It gives me an opportunity to talk with the patient. It's amazing how many don't have the problem&quot; or need the drug they saw advertised.<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[The best pharma blogs, according to Pharmafocus  Corroxannaa4s Weblog]]></title>
<link>http://www.worldpharmanews.net/Blogs/The_best_pharma_blogs_according_to_Pharmafocus_«_Corroxannarsquos_Weblog/</link>
<comments>http://www.worldpharmanews.net/Blogs/The_best_pharma_blogs_according_to_Pharmafocus_«_Corroxannarsquos_Weblog/</comments>
<pubDate>Sun, 02 Mar 2008 23:32:18 +0200</pubDate>
<dc:creator>alex</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/The_best_pharma_blogs_according_to_Pharmafocus_«_Corroxannarsquos_Weblog/</guid>
<description><![CDATA[The internet loves a good scandal. From compromising celebrity videos to the latest political whisperings, whatever your interest in life, the chances are its seamier side will be covered somewhere on the web.This is just as true for pharma, where industry gossip, rumour and horror stories send many people online and these days their first stop is usually a weblog or blog. Once little more than online diaries, blogs have come to represent a key development in the next generation of internet applications known as Web 2.0.<br/><br/>3 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[The New England Journal of Medicine - Aprotinin during Coronary-Artery Bypass Grafting and Risk of Death ()]]></title>
<link>http://www.worldpharmanews.net/Product/The_New_England_Journal_of_Medicine_-_Aprotinin_during_Coronary-Artery_Bypass_Grafting_and_Risk_of_Death_/</link>
<comments>http://www.worldpharmanews.net/Product/The_New_England_Journal_of_Medicine_-_Aprotinin_during_Coronary-Artery_Bypass_Grafting_and_Risk_of_Death_/</comments>
<pubDate>Sun, 24 Feb 2008 00:21:39 +0200</pubDate>
<dc:creator>alex</dc:creator>
<category>Product</category>
<guid>http://www.worldpharmanews.net/Product/The_New_England_Journal_of_Medicine_-_Aprotinin_during_Coronary-Artery_Bypass_Grafting_and_Risk_of_Death_/</guid>
<description><![CDATA[Conclusions: Patients who received aprotinin alone on the day of CABG surgery had a higher mortality than patients who received aminocaproic acid alone. Characteristics of neither the patients nor the surgeons explain the difference, which persisted through several approaches to control confounding.<br/><br/>3 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Bayer Responds to Trasylol Studies]]></title>
<link>http://www.worldpharmanews.net/Product/Bayer_Responds_to_Trasylol_Studies/</link>
<comments>http://www.worldpharmanews.net/Product/Bayer_Responds_to_Trasylol_Studies/</comments>
<pubDate>Sun, 24 Feb 2008 00:05:38 +0200</pubDate>
<dc:creator>G00gle</dc:creator>
<category>Product</category>
<guid>http://www.worldpharmanews.net/Product/Bayer_Responds_to_Trasylol_Studies/</guid>
<description><![CDATA[Does Bayer have anything to say to the Randone family profiled on 60 Minutes last Sunday? &quot;Bayer would like the Randone family to know we are very sorry for their loss.&quot;<br/><br/>3 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Mark & Associates, P.C. Applauds CBS for Exposing the Tragedy Surrounding Bayer's Trasylol]]></title>
<link>http://www.worldpharmanews.net/Product/Mark__Associates_P-C-_Applauds_CBS_for_Exposing_the_Tragedy_Surrounding_Bayers_Trasylol/</link>
<comments>http://www.worldpharmanews.net/Product/Mark__Associates_P-C-_Applauds_CBS_for_Exposing_the_Tragedy_Surrounding_Bayers_Trasylol/</comments>
<pubDate>Sun, 24 Feb 2008 00:00:08 +0200</pubDate>
<dc:creator>G00gle</dc:creator>
<category>Product</category>
<guid>http://www.worldpharmanews.net/Product/Mark__Associates_P-C-_Applauds_CBS_for_Exposing_the_Tragedy_Surrounding_Bayers_Trasylol/</guid>
<description><![CDATA[Mark &amp; Associates, P.C., a law firm representing victims of medication side effects, applauds 60 Minutes for reporting on the plight of thousands of Trasylol patients and their families. The report not only detailed the unacceptable dangers of the drug, but also the highly disturbing actions of the drug's manufacturer, Bayer Healthcare Pharmaceuticals. Mark &amp; Associates, P.C. is committed to fighting for the legal rights of Trasylol patients.<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Drug Injury Watch: Dr. Dennis Mangano Says On 60 Minutes In February 2008 That Trasylol Should Have Been Recalled As Early As January 2006]]></title>
<link>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Dr-_Dennis_Mangano_Says_On_60_Minutes_In_February_2008_That_Trasylol_Should_Have_Been_Recalled_As_Early_As_January_2006/</link>
<comments>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Dr-_Dennis_Mangano_Says_On_60_Minutes_In_February_2008_That_Trasylol_Should_Have_Been_Recalled_As_Early_As_January_2006/</comments>
<pubDate>Mon, 18 Feb 2008 23:23:13 +0200</pubDate>
<dc:creator>tjlpa</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Dr-_Dennis_Mangano_Says_On_60_Minutes_In_February_2008_That_Trasylol_Should_Have_Been_Recalled_As_Early_As_January_2006/</guid>
<description><![CDATA[Delay By Bayer And FDA Until November 2007, When Trasylol Sales Were &quot;Suspended&quot;, Caused 22,000 Excess Deaths Per CBS Report<br/><br/>4 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Trasylol - One Thousand Lives A Month]]></title>
<link>http://www.worldpharmanews.net/Product/Trasylol®_-_One_Thousand_Lives_A_Month/</link>
<comments>http://www.worldpharmanews.net/Product/Trasylol®_-_One_Thousand_Lives_A_Month/</comments>
<pubDate>Mon, 18 Feb 2008 16:12:18 +0200</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Product</category>
<guid>http://www.worldpharmanews.net/Product/Trasylol®_-_One_Thousand_Lives_A_Month/</guid>
<description><![CDATA[A renowned researcher estimates that 22,000 patients could have been saved if the Food and Drug Administration removed the heart surgery drug Trasylol two years ago. Scott Pelley reports.<br/><br/>4 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[PharmaGossip: Bayer - Trasylol: one thousand lives a month]]></title>
<link>http://www.worldpharmanews.net/Product/PharmaGossip_Bayer_-_Trasylol_one_thousand_lives_a_month/</link>
<comments>http://www.worldpharmanews.net/Product/PharmaGossip_Bayer_-_Trasylol_one_thousand_lives_a_month/</comments>
<pubDate>Mon, 18 Feb 2008 11:44:59 +0200</pubDate>
<dc:creator>PharmaGossip</dc:creator>
<category>Product</category>
<guid>http://www.worldpharmanews.net/Product/PharmaGossip_Bayer_-_Trasylol_one_thousand_lives_a_month/</guid>
<description><![CDATA[Watch the 60 Minutes video clip.<br/><br/>7 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Scientific Misconduct Blog: What is the half-life of a pharmaceutical scientific scandal?]]></title>
<link>http://www.worldpharmanews.net/Blogs/Scientific_Misconduct_Blog_What_is_the_half-life_of_a_pharmaceutical_scientific_scandal/</link>
<comments>http://www.worldpharmanews.net/Blogs/Scientific_Misconduct_Blog_What_is_the_half-life_of_a_pharmaceutical_scientific_scandal/</comments>
<pubDate>Sat, 16 Feb 2008 22:17:22 +0200</pubDate>
<dc:creator>alex</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Scientific_Misconduct_Blog_What_is_the_half-life_of_a_pharmaceutical_scientific_scandal/</guid>
<description><![CDATA[Using Google Trends it is possible to plot the frequency of google searches against time, as well as the incidence of news reports for particular key words (with flags showing the timing of key incidents). I thought it would be interesting to look at a few scientific scandals<br/><br/>3 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Pharmalot  Bayer Delay Over Trasylol Took 22,000 Lives]]></title>
<link>http://www.worldpharmanews.net/Blogs/Pharmalot_-_Bayer_Delay_Over_Trasylol_Took_22000_Lives/</link>
<comments>http://www.worldpharmanews.net/Blogs/Pharmalot_-_Bayer_Delay_Over_Trasylol_Took_22000_Lives/</comments>
<pubDate>Fri, 15 Feb 2008 15:57:20 +0200</pubDate>
<dc:creator>G00gle</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Pharmalot_-_Bayer_Delay_Over_Trasylol_Took_22000_Lives/</guid>
<description><![CDATA[The lives of 22,000 people could have been saved if the FDA removed Bayer's Trasylol two years ago, when his study revealed a growing number of deaths linked to the heart drug. That's what Dennis Mangano, founder of the non-profit Ischemia Research and Educational Foundation, tells 60 Minutes in an interview to be broadcast this weekend, according to CBS News.Mangano, whose January 2006 study in The New England Journal of Medicine showed Trasylol put patients at higher risk of heart attacks, stroke and renal failure, repeats allegations that Bayer failed to tell the FDA about negative results of their own study. Despite his study, an FDA panel declared Trasylol, a drug used to reduce bleeding during bypass procedures, was safe and effective, and voted unanimously to keep the med on the market. (Mangano is pictured to the right).<br/><br/>4 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA["The Rx Business Has Lost Its Heart and Its Soul," Kevin McCauley, Communications Expert]]></title>
<link>http://www.worldpharmanews.net/Blogs/The_Rx_Business_Has_Lost_Its_Heart_and_Its_Soul_Kevin_McCauley_Communications_Expert/</link>
<comments>http://www.worldpharmanews.net/Blogs/The_Rx_Business_Has_Lost_Its_Heart_and_Its_Soul_Kevin_McCauley_Communications_Expert/</comments>
<pubDate>Thu, 14 Feb 2008 16:49:11 +0200</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/The_Rx_Business_Has_Lost_Its_Heart_and_Its_Soul_Kevin_McCauley_Communications_Expert/</guid>
<description><![CDATA[There are lawsuits, legal settlements, recalls, executive firings, employee layoffs, few new drugs in the pipeline.  The pharmaceutical industry is in trouble on many fronts. In this blog post, let's just look at one of the challenges: That's the blow to the industry's reputational capital. This is happening at a time when even the most conservative economists are conceding that at this stage of capitalism there's more to business than primarily maximizing shareholder value.<br/><br/>7 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[PharmaGossip: A "must read" post]]></title>
<link>http://www.worldpharmanews.net/Corporate/PharmaGossip_A_must_read_post/</link>
<comments>http://www.worldpharmanews.net/Corporate/PharmaGossip_A_must_read_post/</comments>
<pubDate>Thu, 14 Feb 2008 15:05:30 +0200</pubDate>
<dc:creator>PharmaGossip</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/PharmaGossip_A_must_read_post/</guid>
<description><![CDATA[Big Pharma has lost its heart and its soul.<br/><br/>3 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Merck Resolves Federal and State Investigations]]></title>
<link>http://www.worldpharmanews.net/Corporate/Merck_Resolves_Federal_and_State_Investigations/</link>
<comments>http://www.worldpharmanews.net/Corporate/Merck_Resolves_Federal_and_State_Investigations/</comments>
<pubDate>Sat, 09 Feb 2008 00:33:32 +0200</pubDate>
<dc:creator>alex</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Merck_Resolves_Federal_and_State_Investigations/</guid>
<description><![CDATA[Merck &amp; Co., Inc. said that it has reached civil settlements with federal and state authorities to resolve longstanding investigations related to disputes over the proper calculation of Medicaid rebates as well as certain past sales and marketing activities that ended in 2001.The settlements do not constitute an admission by Merck of any liability or wrongdoing.  Merck believes its pricing and sales and marketing policies and practices were consistent with all applicable regulations and contracts during the relevant time.<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Manhattan Research Ranks the Top Pharmaceutical Branded Websites by Rx Request Rates]]></title>
<link>http://www.worldpharmanews.net/Research_Development/Manhattan_Research_Ranks_the_Top_Pharmaceutical_Branded_Websites_by_Rx_Request_Rates/</link>
<comments>http://www.worldpharmanews.net/Research_Development/Manhattan_Research_Ranks_the_Top_Pharmaceutical_Branded_Websites_by_Rx_Request_Rates/</comments>
<pubDate>Tue, 05 Feb 2008 01:25:12 +0200</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Research &amp; Development</category>
<guid>http://www.worldpharmanews.net/Research_Development/Manhattan_Research_Ranks_the_Top_Pharmaceutical_Branded_Websites_by_Rx_Request_Rates/</guid>
<description><![CDATA[Manhattan Research, a leader in syndicated research and marketing services for the health and pharmaceutical industry, revealed the top pharmaceutical branded product websites ranked by offline requests by U.S. adult consumers. The product site rankings are based on the comprehensive online consumer research study with 5,112 U.S. adults titled ePharma Consumer v7.0: The Future of Integrated DTC Marketing. In addition to the top product site rankings, the study provides in-depth data on more than 200 leading pharmaceutical product sites including site satisfaction, site search rationales, tools and features desired on product sites, and a wide range of consumer actions taken afterwards.<br/><br/>3 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Medical 2.0: A new section called - Pharma 2.0]]></title>
<link>http://www.worldpharmanews.net/Blogs/Medical_2-0_A_new_section_called_-_Pharma_2-0/</link>
<comments>http://www.worldpharmanews.net/Blogs/Medical_2-0_A_new_section_called_-_Pharma_2-0/</comments>
<pubDate>Mon, 04 Feb 2008 16:55:26 +0200</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Medical_2-0_A_new_section_called_-_Pharma_2-0/</guid>
<description><![CDATA[Its about a new project called worldpharmanews.net. Its aim to be a pioneer in a new section called Pharm 2.0. Worldpharmanews.net is going to be an advanced Web 2.0 pharmaceutical news portal. The concept is simple : to create an on line submission platform for pharmaceutical news.<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Pharmalot  Glaxo Wins Paxil Suicide Case Due To Preemption]]></title>
<link>http://www.worldpharmanews.net/Blogs/Pharmalot_-_Glaxo_Wins_Paxil_Suicide_Case_Due_To_Preemption/</link>
<comments>http://www.worldpharmanews.net/Blogs/Pharmalot_-_Glaxo_Wins_Paxil_Suicide_Case_Due_To_Preemption/</comments>
<pubDate>Sun, 03 Feb 2008 21:03:13 +0200</pubDate>
<dc:creator>alex</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Pharmalot_-_Glaxo_Wins_Paxil_Suicide_Case_Due_To_Preemption/</guid>
<description><![CDATA[A federal judge in California dismissed a case brought by the family of a 13-year-old girl who committed suicide while taking the antidepressant, citing a controversial rule that FDA approval of a drug preempts state lawsuits challenging safety, efficacy, or labeling. At issue is whether patients can sue a drugmaker through state law when a product has already been approved by the FDA, a notion the US Supreme Court is expected to decide after agreeing to review a different case.In the Paxil case, US District Court Judge Frank Damrell, Jr. dismissed the suit &quot;on the grounds that, under state law, all of the claims required showing that Glaxo should have included a warning in Paxil's labeling in 1997 that there was an increased risk of suicidality.&quot; And so he decided the lawsuit created &quot;a direct conflict with the federal labeling requirements for Paxil established&quot; by the FDA, &quot;preempting the plaintif's claims, according to a statement issued by Glaxo's attorneys.<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[eDrugSearch Blog  HEALTH 2.0 INTERVIEW SERIES a4 Matthew Holt and Indu Subaiya discuss the companies to watch in 2008]]></title>
<link>http://www.worldpharmanews.net/Financial/eDrugSearch_Blog_-_HEALTH_2-0_INTERVIEW_SERIES_mdash_Matthew_Holt_and_Indu_Subaiya_discuss_the_companies_to_watch_in_2008/</link>
<comments>http://www.worldpharmanews.net/Financial/eDrugSearch_Blog_-_HEALTH_2-0_INTERVIEW_SERIES_mdash_Matthew_Holt_and_Indu_Subaiya_discuss_the_companies_to_watch_in_2008/</comments>
<pubDate>Sun, 03 Feb 2008 18:49:31 +0200</pubDate>
<dc:creator>carybyrd</dc:creator>
<category>Financial</category>
<guid>http://www.worldpharmanews.net/Financial/eDrugSearch_Blog_-_HEALTH_2-0_INTERVIEW_SERIES_mdash_Matthew_Holt_and_Indu_Subaiya_discuss_the_companies_to_watch_in_2008/</guid>
<description><![CDATA[Matthew Holt and Indu Subaiya are the chief organizers of the Health 2.0 Connecting Consumers and Providers conference, which will take place March 3-4 in San Diego. Matthew is a healthcare strategist and author of perhaps the industry's most influential blog, The Health Care Blog. Indu is an MD and founder of Etude Scientific, which consults with healthcare and life science companies on new ventures.<br/><br/>4 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Pharma Marketing Blog: DocCheck  Physician Social Network Comes to US]]></title>
<link>http://www.worldpharmanews.net/Blogs/Pharma_Marketing_Blog_DocCheck®__Physician_Social_Network_Comes_to_US/</link>
<comments>http://www.worldpharmanews.net/Blogs/Pharma_Marketing_Blog_DocCheck®__Physician_Social_Network_Comes_to_US/</comments>
<pubDate>Fri, 01 Feb 2008 23:05:54 +0200</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Pharma_Marketing_Blog_DocCheck®__Physician_Social_Network_Comes_to_US/</guid>
<description><![CDATA[Back in December, 2005, I was invited by Dr. Frank Antwerpes (photo on left), CEO of DocCheck, a German Internet portal for physicians, to his European Medical Portal Meeting in Berlin, Germany. I had a great time there and stayed at the upscale, but hard to find, Hotel Q!, winner of the Travel &amp; Leisure's Design Award 2005 (Best Design Hotel) and located a few steps from Kurfrstendamm, Berlin's famous shopping mile packed with boutiques, restaurants, bars and galleries.<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Pharma's Cutting Edge  A PR virus for Pharma]]></title>
<link>http://www.worldpharmanews.net/Blogs/Pharmas_Cutting_Edge_-_A_PR_virus_for_Pharma/</link>
<comments>http://www.worldpharmanews.net/Blogs/Pharmas_Cutting_Edge_-_A_PR_virus_for_Pharma/</comments>
<pubDate>Fri, 01 Feb 2008 23:00:47 +0200</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Pharmas_Cutting_Edge_-_A_PR_virus_for_Pharma/</guid>
<description><![CDATA[In November 2007, Harris Interactive published their annual poll of Americans attitudes towards industrial regulation by government and the trustworthiness of industries.  I made the above chart using data from that poll.  It shows the percentage of people polled who believe that the referenced industry is generally trustworthy and honest.<br/><br/>3 Vote(s) ]]></description>
</item>

</channel>
</rss>
